At WIRED Health 2025, Orchid CEO Noor Siddiqui and the genomics pioneer George Church laid out their view of the future of genetic screening. The world of pregnancy is going to radically change, predicts Noor Siddiqui. "I think that the default way people are going to choose to have kids is via IVF and embryo screening," she said at the WIRED Health summit last week. "There's just a massive amount of risk that you can take off of the table." Siddiqui is the founder and CEO of Orchid, a biotech company that offers whole-genome screening of embryos for IVF.

In this paper, we consider the problem of detecting unknown cyberattacks from audit data of system-level events. A key challenge is that different cyberattacks will have different suspicion indicators, which are not known beforehand. To address this we consider a multi-view anomaly detection framework, where multiple expert-designed views" of the data are created for capturing features that may serve as potential indicators. Anomaly detectors are then applied to each view and the results are combined to yield an overall suspiciousness ranking of system entities. Unfortunately, there is often a mismatch between what anomaly detection algorithms find and what is actually malicious, which can result in many false positives.

To understand AIOps, it helps to consider one very weird thought: the technological systems that we humans have built have become too complex to be managed by mere humans. Specifically, the IT operations that run businesses have galloped forward in complexity, leaving their human masters in semi-bewilderment. It's a great irony of human intelligence: we've built IT systems that are so advanced that they are, in essence, overwhelming us. Things didn't use to be this snarled. In the pre-cloud era of yore, monitoring our data centers was comparatively simple.

Humans are good at a lot of things, but when it comes to assessing risk in the modern world we have some serious limitations. It's not uncommon to be plagued with fear and anxiety while flying, for example, but the same people who quake at the thought of trusting their life to an airliner will often treat the far more dangerous task of driving with baffling nonchalance. It should be no surprise then, that people are also wildly off the mark when it comes to assessing the risks presented by public road testing of autonomous vehicles. This misperception of risk is dramatically illustrated in a recent story by Washington Post reporter Faiz Siddiqui, which uncovers a kind of NIMBY (Not In My Back Yard) backlash against AVs in the heart of Silicon Valley. Siddiqui spoke with a number of Valley residents, most of whom work in the tech sector and believe in the long term potential of self-driving cars, who object to being what one terms "the guinea pig" for this new technology.

LAGUNA NIGUEL, Calif.--For decades, innovators have been holding a candle for the potential of Big Data to one day revolutionize health care. Entrepreneurs have developed ways for people to track their own biological metrics, and for companies to use advances like artificial intelligence to provide more targeted care. Are we finally at the point where data can lead to tangible changes in health care? Or is still an unfulfilled promise? Medical experts at Fortune magazine's Brainstorm Health conference discussed the promise and continued challenges of mining health data for insights.

People spend more and more time on their smartphones, but with such a limited set of apps that it's becoming harder and harder for newcomers to reach them. Chatbots are the solution, two proponents told a crowded ballroom at SXSW on Saturday, day two of the conference. That's because they play out on one of the entrenched sets of apps that people already chronically use, they argued: messaging apps. "We believe that conversations will become the new user interface," said Laura Newton, a product manager at the youth-oriented messaging app Kik. Consumers don't know what to expect from bots, but are easily disappointed.

In a warehouse outside of Kigali, Rwanda, 15 drones sit waiting to receive a message. When the text comes in, one loads up and zips off into the sky – on a mission to save a life. Today, the government of Rwanda announced an emergency drone delivery service. These drones will make up to 150 trips per day, carrying blood supplies to clinics in need. Rwanda has relatively good infrastructure in some places, but in others it can be unreliable, says Moz Siddiqui at the Global Alliance for Vaccines and Immunization (GAVI), one of the partners in the project, along with UPS and California drone company Zipline.

If you're old enough to have had an AOL Instant Messenger account, then you may remember Jill020306, a curious teenager who kept getting creepy phone calls she couldn't resist answering. As part of the marketing campaign for the 2006 horror flick When A Stranger Calls, the ad agency Universal McCann built a chatbot that would play the part of Jill Johnson in an AOL Instant Messenger conversation. What's old is new again and today Sequel, "the chatbot platform that enables creators and brands to build conversational personas for entertainment and media," has launched an experience to help market Now You See Me 2. Things have changed, technologically and otherwise, in the past ten years. Sequel's bot focuses on Kik and Facebook Messenger, not AOL. Besides the platform changing, the bigger question worth answering is, has the technology powering chatbots improved to a point where they might offer something more than a mildly amusing piece of marketing campaign?